|1.||Aziz, A: 1 article (01/2012)|
|2.||Baqui, M N: 1 article (01/2012)|
|3.||Rahman, M J: 1 article (01/2012)|
|4.||Rahman, F: 1 article (01/2012)|
|5.||Begum, M: 1 article (01/2012)|
|6.||Debnath, R C: 1 article (01/2012)|
|7.||Kabir, A L: 1 article (01/2012)|
|8.||Dipta, T F: 1 article (01/2012)|
|9.||Habib, M A: 1 article (01/2012)|
01/01/2012 - "Six out of ten patients with refractory multiple myeloma displayed minimal response (60%) after treatment with 6 cycle of VMCP protocol, three patients entered partial remission (30%), and one (10%) showed complete response."
07/13/1990 - "In four other anaemic patients with multiple myeloma, stage III, treated according to the VMCP protocol but without additional interferon, erythropoietin did not improve erythropoiesis."
07/13/1990 - "In a 59-year-old man with multiple myeloma (kappa-light chain paraproteinaemia) in stage IIIB, bone marrow infiltration with atypical plasma cells was reduced by five cytostatic treatment courses with vincristine, melphalan, cyclophosphamide and prednisone (VMCP protocol), but anaemia requiring blood transfusion persisted (haemoglobin concentration 5.3 g/dl). "
|2.||Blood Transfusion (Blood Transfusions)